These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 331886)
41. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus. Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312 [TBL] [Abstract][Full Text] [Related]
42. The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients, and in rheumatoid-like disease. Klajman A; Kafri B; Shohat T; Drucker I; Moalem T; Jaretzky A Clin Immunol Immunopathol; 1983 Apr; 27(1):1-8. PubMed ID: 6603311 [TBL] [Abstract][Full Text] [Related]
43. Antinuclear antibodies measured by enzyme immunoassay in patients with systemic lupus erythematosus: relation to disease activity. Paz E; Adawi M; Lavi I; Mussel Y; Mader R Rheumatol Int; 2007 Aug; 27(10):941-5. PubMed ID: 17639400 [TBL] [Abstract][Full Text] [Related]
44. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology]. Kahn MF; Dryll A; de Seze S J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873 [No Abstract] [Full Text] [Related]
45. The clinical significance of the antinuclear antibody test as a screening procedure for DNA antibodies in SLE. El-Ghobarey AE; Sloane DJ; Whaley K Scott Med J; 1980 Oct; 25(4):293-8. PubMed ID: 7010591 [TBL] [Abstract][Full Text] [Related]
46. Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease. Provost TT; Razzaque A; Maddison PJ; Reichlin M Arthritis Rheum; 1977; 20(8):1457-63. PubMed ID: 303519 [TBL] [Abstract][Full Text] [Related]
47. Antinuclear antibodies in pleural fluid. Khare V; Baethge B; Lang S; Wolf RE; Campbell GD Chest; 1994 Sep; 106(3):866-71. PubMed ID: 8082370 [TBL] [Abstract][Full Text] [Related]
48. Antinuclear antibodies as indicators for the procainamide-induced systemic lupus erythematosus-like syndrome and its clinical presentations. Gorsulowsky DC; Bank PW; Goldberg AD; Lee TG; Heinzerling RH; Burnham TK J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):245-53. PubMed ID: 3882781 [TBL] [Abstract][Full Text] [Related]
49. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus. Alcover A; Molano J; Renart J; Gil-Aguado A; Nieto A; Avila J Arthritis Rheum; 1984 Aug; 27(8):922-8. PubMed ID: 6380505 [TBL] [Abstract][Full Text] [Related]
50. The clinical application of an ELISA technique for the detection of antihistone antibodies. Epstein A; Greenberg M; Halbert S; Kramer L; Barland P J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897 [TBL] [Abstract][Full Text] [Related]
51. Increased serum aminotransferases associated with anti-mitochondrial antibodies in systemic lupus erythematosus patients with autoimmune liver disease. Li CH; Xu PS; Wang CY; Zou GL Clin Chim Acta; 2006 Mar; 365(1-2):135-42. PubMed ID: 16182269 [TBL] [Abstract][Full Text] [Related]
52. Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. Bernstein RM; Hobbs RN; Lea DJ; Ward DJ; Hughes GR Arthritis Rheum; 1985 Mar; 28(3):285-93. PubMed ID: 3872129 [TBL] [Abstract][Full Text] [Related]
53. Antinuclear antibody (ANA) patterns in hepatic and extrahepatic autoimmune disease. Strassburg CP; Manns MP J Hepatol; 1999 Oct; 31(4):751. PubMed ID: 10551402 [No Abstract] [Full Text] [Related]
54. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome. Freundlich B; Makover D; Maul GG Ann Intern Med; 1988 Aug; 109(4):295-7. PubMed ID: 3293493 [TBL] [Abstract][Full Text] [Related]
55. Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Maddison PJ; Provost TT; Reichlin M Medicine (Baltimore); 1981 Mar; 60(2):87-94. PubMed ID: 6971388 [TBL] [Abstract][Full Text] [Related]
56. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus. Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398 [TBL] [Abstract][Full Text] [Related]
57. Pneumatosis cystoides intestinalis and benign pneumoperitoneum in a patient with antinuclear antibody negative systemic lupus erythematosus. Pruitt RE; Tumminello VV; Reveille JD J Rheumatol; 1988 Oct; 15(10):1575-7. PubMed ID: 3264581 [TBL] [Abstract][Full Text] [Related]
58. Lupus erythematosus cells in serum and pleural fluid of a patient with negative fluorescent antinuclear antibody test. Hidalgo C; Vladutiu AO Am J Clin Pathol; 1987 May; 87(5):660-2. PubMed ID: 3554976 [TBL] [Abstract][Full Text] [Related]
59. Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus. Tron F; Jacob L; Bach JF Adv Nephrol Necker Hosp; 1983; 12():215-37. PubMed ID: 6188347 [No Abstract] [Full Text] [Related]
60. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)]. Horvat Z Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]